Dr. Elise Belilos, MD

Dr. Belilos practices at NYU Langone Hospitals - Long Island in Mineola, New York.

Dr. Belilos' NPI, 1639150550, was assigned on November 8, 2005. Dr. Belilos graduated from Renaissance School of Medicine at Stony Brook University in 1986. Dr. Belilos holds New York license NYS176098.

Dr. Belilos' primary practice is NYU Langone Hospitals - Long Island, at 259 1st St, Mineola, NY 11501 in Nassau County. The practice phone is (516) 576-1820.

Dr. Belilos' primary practice is NYU Langone Hospitals - Long Island in Mineola, New York. Dr. Belilos is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Belilos to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Belilos practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Belilos' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Belilos is board certified in internal medicine by the American Board of Internal Medicine. Dr. Belilos is licensed in New York.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, lupus, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Belilos treats.

CMS data shows 679 Medicare services from Dr. Belilos across 10 procedure codes in 2024, for 173 Medicare patients. Medicare paid $38,860 for them.

CMS counts 173 Medicare patients who saw Dr. Belilos in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have arthritis, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Belilos' median patient age at 65, with 73% women.

In 2024, Dr. Belilos wrote 351 Medicare Part D claims for 54 patients. 84% of them were for generic drugs. CMS names the drug for 211 of them, across 9 drugs with 11 or more claims each, at $189,928 in total drug cost. In 2023, CMS named 307 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Belilos for performance year 2024, reported as part of a group. Dr. Belilos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Belilos as offering telehealth.

Dmand AI links 10 papers to Dr. Belilos, published from 2009 to 2024. 2013 was the busiest year, with 2. The most frequent topics are Atherosclerosis, Cholesterol and Diagnosis, Differential. Dr. Belilos' most frequent co-authors are Steven Eric Carsons, MD, Kristina Belostocki, MD and Christopher Campese, MD.

CMS Open Payments shows 2 general payments to Dr. Belilos from 2 drug and device companies from 2017 to 2025. Education make up the largest share, 79% of the total. Janssen Pharmaceuticals, Inc paid the most, $45.

Dmand AI lists 3 awards for Dr. Belilos, most recently Newsday - Top Doctors on Long Island in 2018.

Dr. Belilos graduated from Renaissance School of Medicine at Stony Brook University in 1986. Dr. Belilos is a member of ACR.

Dr. Belilos is in network with 16 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.